J7040 HCPCS code: Infusion, normal saline solution, sterile (500 ml = 1 unit)
J7040 is the HCPCS Level II code for infusion, normal saline solution, sterile (500 ml = 1 unit). In 2024 Medicare paid an average of $1.00 per service for J7040 across 201,686 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 12 per day on outpatient hospital claims. Medicare volume rose 3% from 2022 to 2024 (195,939 to 201,686 services). In 2024, about 8,624 clinicians billed Medicare for J7040 for 55,721 beneficiaries; California, New York, Florida accounted for 44% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1984-01-01 |
| Last action effective | 1997-01-01 |
Who bills J7040 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 8,624 |
| Medicare beneficiaries | 55,721 |
| States with claims | 54 |
| Share of services in top 3 states (California, New York, Florida) | 44% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J7040, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 195,939 | 54,468 | $1.30 | $1.02 |
| 2023 | 207,690 | 55,497 | $1.25 | $0.98 |
| 2024 | 201,686 | 55,721 | $1.28 | $1.00 |
States with the most J7040 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 48,923 | $0.98 |
| New York | 20,196 | $1.00 |
| Florida | 20,019 | $1.02 |
| Texas | 12,718 | $1.01 |
| South Carolina | 12,421 | $1.02 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 12 | Clinical: Data |
| practitioner claims | 6 | Clinical: Data |
Medicare policy articles for this code
- A57114: Billing and Coding: Trigger Point Injections (First Coast Service Options, Inc. (MAC - Part B))
- A57751: Billing and Coding: Trigger Point Injections (Novitas Solutions, Inc. (MAC - Part A, MAC - Part B))
Covered diagnoses (2 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| M79.12 | Myalgia of auxiliary muscles, head and neck | 2 |
| M79.18 | Myalgia, other site | 2 |
What changed for J7040
- 1984-01-01: J7040 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7040?
J7040 is the HCPCS Level II code for infusion, normal saline solution, sterile (500 ml = 1 unit). Short descriptor: "Normal saline solution infus".
How much does Medicare pay for J7040?
In 2024, the average Medicare payment was $1.00 per service (average allowed $1.28).
Does Medicare cover J7040?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Which diagnoses support coverage for J7040?
Medicare policy articles that cite J7040 list 2 covered ICD-10-CM diagnosis codes across 2 articles. The most cited include M79.12 (Myalgia of auxiliary muscles, head and neck), M79.18 (Myalgia, other site). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J7040 can be billed per day?
12 on outpatient hospital claims; 6 on practitioner claims (NCCI medically unlikely edits).
Related J70 codes
- J7030 — Infusion, normal saline solution , 1000 cc
- J7042 — 5% dextrose/normal saline (500 ml = 1 unit)
- J7050 — Infusion, normal saline solution, 250 cc
- J7060 — 5% dextrose/water (500 ml = 1 unit)
- J7070 — Infusion, d5w, 1000 cc
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7040
- Watch J7040 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7040
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.